 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
 |
 |
 |
 |
 |
 |
Keywords: |
 |
MRS (Magnetic Resonance Spectroscopic) |
 |
 |
 |
 |
Phase: |
 |
Phase 1 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1605
NCT00001574
|
 |
 |
 |
 |
Age Group: |
 |
Adult And Pediatric |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: Y
Recurrent: Y
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/27/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Any Malignant Brain Tumor Brainstem Glioma Ependyoma Germ Cell Tumors Glioblastoma Multiforme Medulloblastoma Metastatic Brain Tumor Oligodendroglioma High Grade Oligodendroglioma Low Grade Pediatric Brain Tumors PNET Tumor Recurrent Malignant Pediatric Brain Tumors |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
This study will be conducted to determine NMRS imaging patterns before, during and after chemotherapy in pediatric patients with primary or metastatic brain tumors in an attempt to identify and characterize specific patterns of metabolites related to tumor regrowth, tumor response to therapy, edema or necrosis.
Patients entered on this trial will also be entered on one of the Branch`s primary brain tumor treatment trials (e.g., phenylacetate, phenylbutyrate, SU-101) or on the Natural History or Standard Therapy protocols. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Less-Toxics. |
 |
 |
 |
 |
Contact: |
 |
National Cancer Institute Kathy Warren, MD Pediatric Oncology Branch Bldg 10 CRC Rm 1-3930 Bethesda, MD 20892 Phone:(301)402-6298 Fax: (301)480-2246 Click here to send an email Website: www-dcs.nci.nih.gov/trials |
 |
 |